Akira Ishiguro

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Synergism of BSF-2/interleukin 6 and interleukin 3 on development of multipotential hemopoietic progenitors in serum-free culture.

K Koike, Tatsutoshi Nakahata, M Takagi et al. · The Journal of Experimental Medicine · 1988 · 158 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +11

A multicentre, open‐label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors

Midori Shima, Keiji Nogami, Sayaka Nagami et al. · Haemophilia · 2019 · 156 citations · Full text

Medicine, Hematology, Pharmacology +11

Loss of function mutations in <i>RPL27</i> and <i>RPS27</i> identified by whole‐exome sequencing in Diamond‐Blackfan anaemia

Runan Wang, Kenichi Yoshida, Tsutomu Toki et al. · British Journal of Haematology · 2014 · 108 citations · Full text

Life Sciences, Genetics, Hematology +11

Extensive proliferation of mature connective-tissue type mast cells in vitro

Tatsutoshi Nakahata, T Kobayashi, Akira Ishiguro et al. · Nature · 1986 · 97 citations

Life Sciences, Cell Biology, Immunology +11